Your browser doesn't support javascript.
loading
Reply letter to "response to article by Johnna Perdrizet et al." by Gomez and colleagues.
Perdrizet, Johnna; Santana, Carlos Felipe S; Senna, Thais; Alexandre, Rodrigo Fernandes; Sini de Almeida, Rodrigo; Spinardi, Julia; Wasserman, Matt.
Affiliation
  • Perdrizet J; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.
  • Santana CFS; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.
  • Senna T; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.
  • Alexandre RF; Health Economics and Outcomes Research, Pfizer Inc, Sao Paulo, Brazil.
  • Sini de Almeida R; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.
  • Spinardi J; Medical and Scientific Affairs, Pfizer Inc, Sao Paulo, Brazil.
  • Wasserman M; Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA.
Hum Vaccin Immunother ; 18(1): 1917237, 2022 12 31.
Article in En | MEDLINE | ID: mdl-33908816
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections Type of study: Prognostic_studies Limits: Humans / Infant Country/Region as subject: America do sul / Brasil Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumococcal Infections Type of study: Prognostic_studies Limits: Humans / Infant Country/Region as subject: America do sul / Brasil Language: En Journal: Hum Vaccin Immunother Year: 2022 Document type: Article Affiliation country: United States Country of publication: United States